Defining the Value of a Comparative Approach to Cancer Drug Development.
about
Improving the Predictive Value of Preclinical Studies in Support of Radiotherapy Clinical Trials.Creation of an NCI comparative brain tumor consortium: informing the translation of new knowledge from canine to human brain tumor patients.Therapeutic Innovations: Tyrosine Kinase Inhibitors in Cancer.Immunotherapy for Dogs: Running Behind Humans.Multi-color flow cytometry for evaluating age-related changes in memory lymphocyte subsets in dogs
P2860
Defining the Value of a Comparative Approach to Cancer Drug Development.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 28 December 2015
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Defining the Value of a Comparative Approach to Cancer Drug Development.
@en
Defining the Value of a Comparative Approach to Cancer Drug Development.
@nl
type
label
Defining the Value of a Comparative Approach to Cancer Drug Development.
@en
Defining the Value of a Comparative Approach to Cancer Drug Development.
@nl
prefLabel
Defining the Value of a Comparative Approach to Cancer Drug Development.
@en
Defining the Value of a Comparative Approach to Cancer Drug Development.
@nl
P2093
P2860
P1476
Defining the Value of a Comparative Approach to Cancer Drug Development.
@en
P2093
Amy K LeBlanc
Chand Khanna
Christina N Mazcko
P2860
P304
P356
10.1158/1078-0432.CCR-15-2347
P407
P577
2015-12-28T00:00:00Z